Ignite Creation Date:
2024-05-06 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 1:55 PM
Study NCT ID:
NCT04732221
Status:
COMPLETED
Last Update Posted:
2024-06-06
First Post:
2021-01-27
Brief Title:
A Study of the Efficacy and Safety of MK-5475 in Participants With Pulmonary Arterial Hypertension INSIGNIA-PAH Phase 23 Study of an Inhaled sGC Stimulator in PAH MK-5475-007
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-19
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-15
Completion Date Type:
ESTIMATED
First Submit Date:
2021-01-27
First Submit QC Date:
January 27 2021
Study First Post Date:
2021-02-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-18
Last Update Post Date:
2024-06-06
Last Update Post Date Type:
ACTUAL